Skip to main content
. Author manuscript; available in PMC: 2024 Oct 1.
Published in final edited form as: Contemp Clin Trials. 2023 Aug 23;133:107318. doi: 10.1016/j.cct.2023.107318

Table 1.

Baseline Characteristics of PATH Pilot RCT Participants by treatment arm

Characteristic PATH Treatment n=41 Control n=41 P-value
Race, n (%)
White 24 (58.4) 23 (48.9)
Black 16 (39.0) 17 (41.5) .975
Others 1 (2.44) 1 (2.44)
Female, n (%) 33 (80.5) 33 (80.5) 1.000
Age (years), mean ± SD 55.9 ± 8.0 55.9 ± 8.5 1.000
Education category
< 4 years of college, n (%) 17 (41.5) 14 (34.2) .494
≥ 4 years of college, n (%) 24 (58.5) 27 (65.6)
Employment category
Unemployed/retired, n (%) 27 (65.9) 28 (68.3) .814
Employed/self-employed, n (%) 14 (34.2) 13 (31.7)
BMI (kg/m2), mean ± SD 35.9 ± 6.8 35.2 ± 5.8 .398
Systolic BP, mean ± SD 120.9 ± 17.3 123.8 ± 15.5 .413
Diastolic BP, mean ± SD 79.9 ± 8.9 80.7 ± 8.6 .418
Self-reported weekly MVPA using MAQ, mean ± SD 103.6 (100.1) 97.0 (83.7) .749
Objective weekly MVPA minutes, mean ± SD 196.4 ± 151.2 208.1 ± 150.1 .727
Adherence to MVPA guidelines (≥150 mins/wk), n (%) 22 (53.7) 19 (46.3) .508
Objective average daily steps, mean ± SD 4889.1 (3077.9) 4629.8 (2561.1) .680
Adherence to steps guidelines (≥7500 steps/day), n (%) 8 (19.5) 9 (22.0) .785